Clinical Trial Update: Intestinal Microbiome Transplant in ALS [Phase 1, Phase 2]

View source ↗

Summary

A Duke University-sponsored Phase 1/2 clinical trial is evaluating an intestinal microbiome transplant for amyotrophic lateral sclerosis (ALS), currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Duke University | Conditions: Amyotrophic Lateral Sclerosis ALS | Phase 1, Phase 2 | Status: RECRUITING